查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986746

移植市場：按產品、應用、最終用戶和地區分類，2026-2034 年

Transplantation Market by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End User (Hospitals, Transplantation Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球器官移植市場規模達187億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到360億美元，2026年至2034年的複合年成長率（CAGR）為7.34%。該市場正經歷顯著成長，其促進因素包括醫療技術的快速進步、慢性病患病率的上升、各國政府和非政府組織（NGO）加強推廣器官捐贈、專業移植中心的擴張以及醫療政策和保險覆蓋範圍的改善。

移植市場分析

  • 市場成長與規模：受快速的技術進步、慢性病盛行率上升以及醫療保健政策改善的推動，市場呈現穩定成長態勢。
  • 市場主要促進因素：影響市場成長的主要因素包括醫療技術的快速進步、慢性疾病導致的器官衰竭率上升、移植中心的擴張、政府支持措施以及醫療政策的演變。
  • 主要市場趨勢：主要市場趨勢包括持續轉型為個人化移植醫學以及生物工程器官和組織的應用。此外，對新型免疫抑制劑和保存方案研發投入的增加也推動了市場成長。
  • 區域趨勢：北美憑藉其先進的醫療保健體系、高移植率和健全的器官捐贈網路，引領市場發展。中東和非洲也呈現顯著成長，這得益於醫療基礎設施的改善和意識提升。
  • 競爭格局：該市場的特點是主要企業積極尋求策略性併購和合作，致力於拓展產品系列和全球影響力。此外，這些公司也集中投資於研發，用於配方、組織工程和器官保存技術的創新。
  • 挑戰與機會：該市場面臨許多挑戰，包括器官捐贈者短缺、器官捐贈相關的倫理問題以及醫療資源取得方面的區域差異。然而，組織工程技術的進步以及旨在支持公平取得移植服務的政策制定，正為市場成長創造新的機會。

移植市場趨勢

移植技術的快速發展

外科技術、免疫抑制劑和器官保存技術的不斷進步和創新，提高了移植成功率和患者預後，為市場成長創造了積極的前景。同時，微創手術技術的進步縮短了恢復時間，減少了併發症，從而提高了器官移植的可行性和普及度，也對市場成長產生了積極影響。此外，組織配型和相容性評估技術的快速發展，最大限度地降低了器官排斥的風險，也推動了市場成長。此外，將數位技術和人工智慧（AI）技術應用於移植領域，旨在實現更準確、更快速的器官相容性評估、患者預後預測和移植後護理管理，也促進了市場成長。

慢性疾病和器官衰竭的盛行率增加

糖尿病、高血壓和心臟病等慢性疾病的日益普遍導致器官移植需求增加，成為市場成長的主要驅動力。反過來，糖尿病和高血壓導致的腎衰竭發生率上升，進而推高了全球腎臟移植需求，進一步促進了市場成長。此外，心臟和肝臟疾病診斷數量的增加，以及由此導致的心臟和肝臟移植需求的成長，也推動了市場成長。此外，老年人口的成長，尤其是老年人更容易患上導致器官衰竭的慢性疾病，也為市場帶來了良好的前景。而且，人們對各種健康狀況的認知不斷提高，診斷技術的進步，使得早期發現需要移植的患者變得更加容易，從而進一步促進了市場成長。

各國政府及非政府組織加強推廣器官捐贈

各國政府和非政府組織（NGO）日益增強的器官捐贈推廣影響力正積極推動市場成長。這促使公眾意識宣傳活動不斷加強，捐贈流程日益簡化，相關立法也得到完善，從而提高了器官捐贈者的數量，進而推動了市場成長。此外，政府和非政府組織與醫療機構加強合作，簡化器官捐贈流程，也促進了市場成長。同時，將家屬同意納入捐贈流程的政策訂定以及全國性捐贈者登記系統的建立，也推動了市場成長。最後，加強國際合作，共用器官捐贈的最佳實踐和資源，並強化全球移植網路，也為市場成長提供了支持。

移植中心和服務擴展

全球範圍內專業移植中心和服務數量的不斷成長和規模的擴大正在推動市場成長。這些專業中心配備了先進的設施和技術精湛的專業人員，能夠進行複雜的移植手術。因此，為了滿足日益成長的治療需求並擴大移植服務的覆蓋範圍，這些中心的建立正在推動市場成長。此外，專注於專業移植和個人化護理的中心，提供包括移植前諮詢、先進手術以及移植後後續觀察和復健在內的綜合服務，也在促進市場成長。同時，中心向農村和醫療資源匱乏地區的擴張，使更多人能夠獲得移植服務，進一步推動了市場成長。

醫療保單和保險範圍擴大

政府推出的各項醫療政策，例如財政援助、報銷計劃和保險覆蓋範圍，為器官移植手術提供支持，顯著促進了市場成長。此外，加強不同醫療體系間移植手術流程和費用的標準化工作也推動了市場成長。同時，涵蓋長期術後照護費用的醫療服務（例如免疫抑制劑治療和定期監測排斥徵兆及併發症）的整合也促進了市場成長。此外，政策制定者日益關注器官移植服務的公平性，致力於解決不同社會經濟群體、種族和地區間移植率的差異，也推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球移植市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 組織製品
  • 免疫抑制劑
  • 防腐液

第7章 市場區隔：依應用領域分類

  • 器官移植
  • 組織移植

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 移植中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進因素、阻礙因素和機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • 21st Century Medicine
    • AbbVie Inc.
    • Arthrex Inc.
    • Astellas Pharma Inc.
    • BioLife Solutions Inc.
    • CareDx Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • TransMedics Inc.
    • Veloxis Pharmaceutical Inc.（Asahi Kasei Corporation）
Product Code: SR112026A7197

The global transplantation market size reached USD 18.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 36.0 Billion by 2034, exhibiting a growth rate (CAGR) of 7.34% during 2026-2034. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

  • Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.
  • Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.
  • Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.
  • Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.
  • Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.
  • Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends :

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

Breakup by Product:

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Tissue products account for the majority of the market share

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

  • Organ Transplantation
  • Tissue Transplantation

Tissue transplantation holds the largest share in the industry

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

  • Hospitals
  • Transplantation Centers
  • Others

Hospitals represent the leading market segment

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • 21st Century Medicine
  • AbbVie Inc.
  • Arthrex Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • CareDx Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • TransMedics Inc.
  • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Key Questions Answered in This Report

  • 1.How big is the global transplantation market?
  • 2.What is the expected growth rate of the global transplantation market during 2026-2034?
  • 3.What are the key factors driving the global transplantation market?
  • 4.What has been the impact of COVID-19 on the global transplantation market?
  • 5.What is the breakup of the global transplantation market based on the product?
  • 6.What is the breakup of the global transplantation market based on the application?
  • 7.What is the breakup of the global transplantation market based on the end user?
  • 8.What are the key regions in the global transplantation market?
  • 9.Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transplantation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Tissue Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressive Drugs
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Preservation Solution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Organ Transplantation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Transplantation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Transplantation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 21st Century Medicine
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Arthrex Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 BioLife Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 CareDx Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 TransMedics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Transplantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transplantation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Transplantation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Transplantation Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Transplantation Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Transplantation Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Transplantation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Transplantation (Tissue Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Transplantation (Tissue Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Transplantation (Immunosuppressive Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Transplantation (Immunosuppressive Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Transplantation (Preservation Solution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Transplantation (Preservation Solution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Transplantation (Organ Transplantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Transplantation (Organ Transplantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Transplantation (Tissue Transplantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Transplantation (Tissue Transplantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Transplantation (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Transplantation (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Transplantation (Transplantation Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Transplantation (Transplantation Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Transplantation (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Transplantation (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Transplantation Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Transplantation Industry: Drivers, Restraints, and Opportunities
  • Figure 74: Global: Transplantation Industry: Value Chain Analysis
  • Figure 75: Global: Transplantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transplantation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Transplantation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Transplantation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Transplantation Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Transplantation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Transplantation Market: Competitive Structure
  • Table 7: Global: Transplantation Market: Key Players